1,495
Views
45
CrossRef citations to date
0
Altmetric
Review

White coat syndrome and its variations: differences and clinical impact

, , &
Pages 73-79 | Published online: 08 Nov 2018

References

  • FryarCDOstchegaYHalesCMHypertension prevalence and control among adults: United States, 2015-2016NCHS Data Brief201728918
  • BurtVLWheltonPRoccellaEJPrevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991Hypertension19952533053137875754
  • PickeringTGGerinWSchwartzARWhat is the white-coat effect and how should it be measured?Blood Press Monit20027629330012488648
  • ChobanianAVBakrisGLBlackHRJoint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating CommitteeSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034261206125214656957
  • BloomfieldDAParkADecoding white coat hypertensionWorld J Clin Cases201753829228352632
  • PickeringTGBlood pressure measurement and detection of hypertensionLancet1994344891431357912303
  • ManciaGBertinieriGGrassiGEffects of blood-pressure measurement by the doctor on patient’s blood pressure and heart rateLancet1983283526956986136837
  • TerraccianoAScuteriAStraitJAre personality traits associated with white-coat and masked hypertension?J Hypertens2014321019871992 discussion 199225186529
  • CalhounDAJonesDTextorSResistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure ResearchHypertension20085161403141918391085
  • WheltonPKCareyRMAronowWS2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesHypertension20187161269132429133354
  • HänninenMRNiiranenTJPuukkaPJTarget organ damage and masked hypertension in the general population: the Finn-Home studyJ Hypertens20133161136114323466942
  • PallaMSaberHKondaSBriasoulisAMasked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysisIntegr Blood Press Control201811112429379316
  • ManciaGFagardRNarkiewiczKTask Force Members2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20133171281135723817082
  • WilliamsBManciaGSpieringWAuthors/Task Force Members2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)2018361019532041
  • WrightJTJrWheltonPKReboussinDMA randomized trial of intensive versus standard blood-pressure controlN Engl J Med201637423229427276569
  • CelisHFagardRHWhite-coat hypertension: a clinical reviewEur J Intern Med200415634835715522568
  • MalachiasMVBGomesMAMNobreF7th Brazilian Guideline of Arterial Hypertension: Chapter 2 - Diagnosis and ClassificationArq Bras Cardiol20161073 Suppl 3713 English, Portuguese27819381
  • BochudMBovetPVollenweiderPAssociation between white-coat effect and blunted dipping of nocturnal blood pressureAm J Hypertens200922101054106119629048
  • CuspidiCMeaniSSalernoMCardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressureJ Hypertens200422227328015076184
  • ModoloRRuggeri BarbaroNde FariaAPThe white-coat effect is an independent predictor of myocardial ischemia in resistant hypertensionBlood Press201423527628024571101
  • de SimoneGSchillaciGChinaliMEstimate of white-coat effect and arterial stiffnessJ Hypertens200725482783117351375
  • FujitaHMatsuokaSAwazuMWhite-Coat and Reverse White-Coat Effects Correlate with 24-h Pulse Pressure and Systolic Blood Pressure Variability in Children and Young AdultsPediatr Cardiol201637234535226481222
  • KristensenKSHøegholmABangLENo impact of blood pressure variability on microalbuminuria and left ventricular geometry: analysis of daytime variation, diurnal variation and ‘white coat’ effectBlood Press Monit20016312513111518834
  • FigueiredoVNMartinsLCBoer-MartinsLThe white coat effect is not associated with additional increase of target organ damage in true resistant hypertensionMed Clin (Barc)201314011522995840
  • CuspidiCSalaCGrassiGManciaGWhite coat hypertension: to treat or not to treat?Curr Hypertens Rep201618118027787835
  • ManciaGBombelliMFacchettiRLong-term risk of sustained hypertension in white-coat or masked hypertensionHypertension200954222623219564548
  • BarochinerJAparicioLSAlfieJArterial Stiffness in Treated Hypertensive Patients With White-Coat HypertensionJ Clin Hypertens (Greenwich)201719161027677467
  • SungSHChengHMWangKLWhite coat hypertension is more risky than prehypertension: important role of arterial wave reflectionsHypertension20136161346135323608649
  • AndrikouITsioufisCDimitriadisKSimilar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotensionBlood Press Monit201116521822321914984
  • ErdoganDCaliskanMGulluHAortic elastic properties and left ventricular diastolic function in white-coat hypertensive individualsBlood Press Monit200611419119816810029
  • LongoDZaettaVPerkovicDImpaired arterial elasticity in young patients with white-coat hypertensionBlood Press Monit20061152432416932033
  • AndroulakisEPapageorgiouNLioudakiESubclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin CJ Clin Hypertens (Greenwich)201719219019727440165
  • LandeMBMeagherCCFisherSGLeft ventricular mass index in children with white coat hypertensionJ Pediatr20081531505418571535
  • IhmSHYounHJParkCSTarget organ status in white-coat hypertensives: usefulness of serum procollagen type I propeptide in the respect of left ventricular diastolic dysfunctionCirc J200973110010519023153
  • MulèGNardiECottoneSMetabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and functionJ Hum Hypertens2007211185486017541385
  • SeemanTPohlMPalyzovaDJohnUMicroalbuminuria in children with primary and white-coat hypertensionPediatr Nephrol201227346146721971642
  • Di MauroSSpallinaGScaliaGUrinary albumin excretion in elderly patients with white coat hypertensionArch Gerontol Geriatr1999281232918656100
  • HøegholmABangLEKristensenKSNielsenJWHolmJMicroalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotensionHypertension19942411011058020997
  • KangYYLiYHuangQFAccuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertensionJ Hypertens20153381580158726103131
  • O’BrienEParatiGStergiouGEuropean Society of Hypertension Working Group on Blood Pressure MonitoringEuropean Society of Hypertension position paper on ambulatory blood pressure monitoringJ Hypertens20133191731176824029863
  • PeacockJDiazKMVieraAJSchwartzJEShimboDUnmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directionsJ Hum Hypertens201428952152824573133
  • AnsteyDEBoothJN3rdAbdallaMPredicted Atherosclerotic Cardiovascular Disease Risk and Masked Hypertension Among Blacks in the Jackson Heart StudyCirc Cardiovasc Qual Outcomes2017107e00342128698190
  • AsayamaKThijsLLiYInternational Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) InvestigatorsSetting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the populationHypertension201464593594225135185
  • FagardRHCornelissenAIncidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysisJ Hypertens200725112193219817921809
  • BanegasJRRuilopeLMde la SierraARelationship between Clinic and Ambulatory Blood-Pressure Measurements and MortalityN Engl J Med2018378161509152029669232
  • YoonHJAhnYParkJBAre metabolic risk factors and target organ damage more frequent in masked hypertension than in white coat hypertension?Clin Exp Hypertens201032748048521029014
  • ScuteriAMorrellCHOrru’MGender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA studyInt J Cardiol2016217929827179214
  • CuspidiCSalaCTadicMUntreated masked hypertension and subclinical cardiac damage: a systematic review and meta-analysisAm J Hypertens201528680681325468808
  • TientcheuDAyersCDasSRTarget Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart StudyJ Am Coll Cardiol662021592169
  • ParatiGStergiouGSAsmarRESH Working Group on Blood Pressure MonitoringEuropean Society of Hypertension practice guidelines for home blood pressure monitoringJ Hum Hypertens2010241277978520520631
  • Sociedade Brasileira de Cardiologia (SBC); Sociedade Brasileira de Hipertensão (SBH); Sociedade Brasileira de Nefrologia (SBN)V Diretrizes Brasileiras de Monitoração Ambulatorial Da Pressão Arterial (MAPA V) e III Diretrizes de Monitoração Residencial da Pressão Arterial (MRPA III) [V Guidelines for ambulatory blood pressure monitoring (ABPM) and III Guidelines for home blood pressure monitoring (HBPM)]Arq Bras Cardiol2011973 Suppl 3124 Portuguese